President Trump had some harsh words for the pharmaceutical industry and pharmacy benefit managers in his speech Friday, but investors bought stocks instead of the vague promises Trump and his administration made to bring down drug prices.
The bottom line: The major pharmaceutical and biotech indices, like the S&P and Nasdaq that include companies like Pfizer and Regeneron, all traded up Friday. The stock prices of Express Scripts and CVS, two leading PBMs, also went up, indicating the industry and investors don't anticipate a major shake-up.